Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.36 USD | -5.13% | -2.72% | -31.19% |
May. 14 | Transcript : Syros Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Syros Pharmaceuticals, Inc. Agrees to Amend Its Loan Agreement with Oxford Finance LLC | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.19% | 143M | |
+64.23% | 62.59B | |
-2.31% | 41.18B | |
+45.21% | 40.29B | |
-8.29% | 27.9B | |
+11.97% | 26.21B | |
-21.16% | 19.09B | |
+7.54% | 13.08B | |
+27.17% | 12.05B | |
+25.72% | 12.26B |
- Stock Market
- Equities
- SYRS Stock
- News Syros Pharmaceuticals, Inc.
- Earnings Flash (SYRS) SYROS PHARMACEUTICALS Reports Q2 Revenue $2.8M, vs. Street Est of $3.5M